Puma Biotechnology | PBYI - Pe Kurs-Gewinn

Aktienkurs
7.56
Täglich Wechseln
-0.22 -2.83%
Monatlich
24.55%
Jährlich
158.02%
Q2 Prognose
7.57




Pe Veränderung Datum
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Daiichi Sankyo 20.73 1.74 2025-12
Esperion Therapeutics 129.79 129 2024-12
Exelixis 602.31 586.25 2025-12
Gilead Sciences 15.63 0.08 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Incyte 14.84 2.79 2025-12
Moderna 27.22 14.51 2023-06
Novartis 17.85 2.11 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Takeda 235.05 184.95 2025-12
TG Therapeutics 10.76 2.32 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06
Vertex Pharmaceuticals 26.15 2.22 2025-12